Migrant Chinese populations in Western countries have a high prevalence of chronic hepatitis B but often experience poor access to health care and late diagnosis. This systematic review aimed to identify obstacles and supports to timely and appropriate health service use among these populations. Systematic searches resulted in 48 relevant studies published between 1996 and 2015. Data extraction and synthesis were informed by models of healthcare access that highlight the interplay of patient, provider and health system factors. There was strong consistent evidence of low levels of knowledge among patients and community members; but interventions that were primarily focused on increasing knowledge had only modest positive effects on testing and/or vaccination. There was strong consistent evidence that Chinese migrants tend to misunderstand the need for health care for hepatitis B and have low satisfaction with services. Stigma was consistently associated with hepatitis B, and there was weak but consistent evidence of stigma acting as a barrier to care. However, available evidence on the effects of providing culturally appropriate services for hepatitis B on increasing uptake is limited. There was strong consistent evidence that health professionals miss opportunities for testing and vaccination. Practitioner education interventions may be important, but evidence of effectiveness is limited. A simple prompt in patient records for primary care physicians improved the uptake of testing, and a dedicated service increased targeted vaccination coverage for newborns.
similar prevalence to their country of origin. [2] [3] [4] There is evidence that
Chinese persons in the UK experience greater mortality rate than the background population from liver cancer 5 and that they endure reduced access to healthcare services for chronic hepatitis B (CHB). [6] [7] [8] This is a growing public health issue for receiving countries, and there is need for better disease surveillance and testing of high-risk migrant groups as well as effective follow-up to ensure infected persons access appropriate health care and their close contacts are appropriately protected, an issue recognized in national policies. 9, 10 Poor access to healthcare services among migrant and other marginalized groups is increasingly recognized as a complex, multifaceted issue. Recent frameworks usefully emphasize the interactive and recursive nature of healthcare access, highlighting the need to understand the interplay between patients, providers and the services on offer. 11, 12 To date, these perspectives have not been used to synthesize the growing body of research that examines hepatitis B among migrant Chinese populations. Several past reviews have addressed particular populations or interventions, but none have employed systematic methods nor provided a comprehensive synthesis that can be applicable in different contexts. [13] [14] [15] The current study adds to our understanding of the barriers and enablers of access to hepatitis B testing and healthcare access for Chinese migrants in Western societies through a systematic and theory-informed evidence synthesis.
| MATERIALS AND METHODS

| A systematic mixed method review
This review adopted a systematic mixed methods approach to identify and integrate relevant evidence from the widest range of primary studies. 16 
| Search strategy
We used a search strategy that aimed to be inclusive by using expanded search terms and by searching both in biomedical databases (Medline, Embase, CINAHL, PsycINFO) and in social sciences databases (ASSIA, Web of Science). We adopted this broad approach to ensure we captured all relevant publications. The search terms were grouped into three areas: the population of interest, healthcare access and experiences, and hepatitis B and are delineated in Table 1 .
| Inclusion/exclusion criteria
An initial screen undertaken by three of the authors (AL, AV and SS) involved a review of the title and/or the abstract, and studies were retained if they focused on (i) individuals identified as Chinese and/or Far East Asian ethnicity living in Europe, North America or Australia/ New Zealand and on (ii) health care (including testing and vaccination) for hepatitis B. Publications that took a purely epidemiological or pathological approach, without investigating factors affecting healthcare access, were excluded, and inclusion and exclusion conflicts were discussed and consensus reached. A second sifting stage involved fulltext review for "richness" and retained only those studies judged to provide sufficient data on influences on healthcare access. Following an initial recommendation for inclusion/exclusion by a senior reviewer, a team of three reviewers agreed the final set of included studies. A methodological quality checklist that combined both generic indicators 16 and indicators of quality for research on ethnicity and health 17 was used. However, as the volume of studies was low, we chose not to exclude on the basis of quality, but rather to moderate the contribution of papers that were of low methodological quality to the final conclusions drawn from the synthesis. Reference lists of included papers identified were then scanned and potentially relevant papers subjected to the same sifting process as described above.
| Data extraction and synthesis
An extraction template was developed and refined iteratively by three members of the research team drawing on access to care frameworks 11, 12 and initial reading of a subset of included papers. Papers were categorized by methodology for analysis: qualitative papers were examined by an anthropologist (EL); quantitative studies by a physician researcher (AV); and interventional studies by a social scientist (SS). NVivo ® was used to code and retrieve material from the qualitative papers, while a template was prepared in a MS Excel ® spread sheet to support the retrieval of relevant information from the quantitative and interventional studies. Extraction codes related to areas influencing individuals' choice and identification of need for healthcare (ie community and family support, health beliefs), health services accessibility and adjudication of perceived need for care (ie practitioners attitudes, knowledge and practice) and wider determinants (ie socio economic barriers, policy, institutional factors). Synthesized memos were prepared initially for each set of studies to correctly classify the studies, their context and the clarity and strength of the evidence of each study. Next, evidence was integrated across the methodologies through discussion and consensus in research meetings. Finally, a series of statements was developed to summarize the available evidence in terms of its strength and consistency (approach adapted from
McLean et al. 18 as described in Table 2 ).
T A B L E 1 Search strategy terms
Criteria
Terms included
Population "Chinese," "Asian continental ancestry group," "Asian Ancestry," "Far East Asian," "Korean," "Taiwan or Taiwanese," "Malaysia or Malaysian," "Asian," "East Asian," "Singapore"
Healthcare access "Barriers," "Access to Health Care" (or health care), "Health services accessibility," "Healthcare disparities," "Patient acceptance of health care," "Health Knowledge, Attitudes, Practice" or "barrier$ to health," "Health behaviour" or "Attitude to health"
Hepatitis B "Hepatitis B, Chronic," "Hepatitis B," "HBV" or "Hepatitis B Virus"
| RESULTS
| Study characteristics
The initial search found 347 publications of which 111 were deemed relevant after abstract screening, and 48 were selected after richness and methodological appraisal ( Figure 1) . Table 3 provide the most robust evidence, their study designs were frequently weak which compromised the strength of the evidence generated.
A few studies took a holistic approach, aiming to examine the interplay between populations and healthcare system actors, but the majority focused solely on patients or members of the public of Chinese or East Asian ethnicity. Among the interventional studies, seven papers referred to multi-component interventions addressing purported obstacles at both the community and healthcare level, [21] [22] [23] [24] [25] [26] [27] four referred to lay health worker interventions, [28] [29] [30] [31] six reported on narrower health education interventions, [32] [33] [34] [35] and two reported on interventions that involved modifications to the healthcare delivery alone. 36, 37 The uptake of HBV testing was the most frequently studied outcome (14 quantitative papers 19, [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] and six interventional papers [21] [22] [23] 26, 27 ). Few papers looked at vaccination uptake (one survey 39 and two interventions 25, 36 ), or the receipt of care/treatment by HBV-infected individuals (three surveys 20, 50, 51 ) and one qualitative paper 52 ). Several papers examined more than one healthcare outcome, particularly those focused on multi-component interventions [21] [22] [23] 26, 27 and the qualitative papers. [52] [53] [54] [55] [56] [57] Theoretical frameworks were infrequently used to inform collection or analysis of data in the quantitative studies. The frameworks used in studies included the "Health Belief Model", 58 Transmission by sexual intercourse was correctly identified by 50%-66% of survey respondents and 80% of patients with CHB. 51 Knowledge of hepatitis B mother-to-child transmission at birth was recognized correctly by 70%-91% of respondents 40, 41, [46] [47] [48] and 85% of patients with hepatitis. 51 One-third to two-thirds were unaware that HBV is more common in China or among Chinese immigrants than among other populations. 40, 42, 60 And while 89% of Chinese American respondents thought HBV would be harmful if they contracted it, only 33% believed that they were at risk. 39 Respondents were unlikely to perceive themselves as being at risk of infection if they had been resident in the UK for a long period. 59 Poor knowledge levels about the disease among the target populations have previously been addressed by designing and delivering educational material in linguistically and culturally tailored ways such as lay health workers, using community venues and through mass media and English language classes. Most studies reported an increase in knowledge levels post-intervention, but this was not necessarily sustained over time and some misconceptions appeared difficult to shift. [30] [31] [32] 62 Importantly, several interventions that achieved an increase in knowledge did not achieve similar increases in uptake of testing or vaccination. 25, 35, 69 A study from Texas, USA, reported significant increases in knowledge among two intervention arms for raising knowledge and awareness among parents (coupled with improved access to low-cost services). However, despite a significant increase in child vaccination rates, these remained below 40% in both intervention groups. 25 A few studies evaluated a Lay Health Worker model involving educational and motivational dimensions in different contexts. [29] [30] [31] 62 They found significant increases in mean knowledge scores and self-reported testing, but concluded that effect sizes on testing were small for the resources needed and that poor knowledge may not be the key factor restricting testing. One randomized trial found self reported testing at six months was significantly different between control groups (6%) and intervention groups (18%). 63 Taylor delivered an educational intervention in ESL classes 67, 68 and similarly found that increased knowledge was accompanied by a weak effect on testing uptake (with just 6% of intervention participants reporting testing at follow-up). 
| There is consistent evidence that stigma around hepatitis B exists, but interventions to address stigma, also addressed other factors thus confounding the evidence on its relevance as a barrier to care
The importance of stigma as an obstacle to HBV healthcare access shows variable results. In a UK study, HBV-related stigma did not show a consistent picture across their ethnically diverse sample of UK respondents and there were no findings specific to Chinese participants. 59 Nevertheless, some participants did report a fear of infection among community members and felt that this could lead to anxiety around eating together and the sharing of utensils.
Two non-UK qualitative studies identified stigma and the fear of disclosure as potentially adversely impacting on access to care as it made it more difficult for patients to keep their disease status secret. 52, 57 Fear of rejection or stigma at a personal and community level also restricted CHB patients from disclosing their status to family and friends as it could lead to exclusion from family and social life in some communities. The stigma seems to arise from a belief that "the way to avoid disease is exclusion".
52
One study addressing stigma found that the "fear of contagion" stigma was most prevalent; 62% of respondents believed that "infected individuals should avoid close contact with others such as kissing and hugging". 48 Stigma associated with the "fear of contagion,"
"negative perception" and "workplace/school stigma" was lower and knowledge levels were higher in people who reported having a relative with hepatitis B.
48
In one Canadian study, a third of participants with hepatitis B, the majority of whom had secondary education and had resided in Canada for over 10 years, were not ashamed and were willing to inform others of their condition. Persons who had resided in Canada for <10 years were less likely to inform others. 51 Markers of stigma were also less common among people with poor knowledge of hepatitis B; for example, "fear of getting a bad test result, embarrassment/shame" was not associated with never having been tested. 45 In contrast, a previous study, Ma et al. (2010) reported that "the fear of a bad test" and "embarrassment or shame" were negatively associated with testing status. 44 .
Exploration of the role of social support, and particularly familylevel support, found that testing was more common among those who had discussed it with their spouse 39 and among those who reported that a family member had suggested it, but less common among those that had not discussed hepatitis B with a partner or family member. 40 However, the direction of the association could not be ascertained and reverse causality could not be excluded from these cross-sectional studies.
Several of the studies of multi-component interventions aimed to address stigma via both individual communication and community-wide efforts, eg mass media, using celebrities, community awareness events held at churches and engagement of community leaders. For example, an intervention for Korean Americans included activity in churches aimed at challenging community-level stigma including messages that emphasized the benefits of being tested for HBV, that such action is the responsible thing to do, and these aimed to challenge the embarrassment or shame associated with HBV infection. 24 However, detailed description of how these were implemented was not provided in the publications and none explicitly reported on any shifts in attitudes or behaviours to suggest reductions in levels of stigma. None of these studies attempted to isolate the effect of reducing stigma on uptake of testing, vaccination or treatment for HBV.
| There is consistent evidence that migrant Chinese populations have low engagement and satisfaction with local health systems
Financial barriers to hepatitis care were reported in several of the US-based qualitative studies. [54] [55] [56] [57] The financial barriers included lack of health insurance 54 and difficulty in getting such insurance. 57 Chinese and Korean participants could not afford screening tests 56 and the practitioners reported being somewhat reluctant to test for and diagnose HBV because of anticipated problems with the affordability of care. 55 However, in a survey study of patients with CHB not receiving treatment, affordability of treatment was seen as possible below certain monthly expenditure and this exceeded the actual out-of-pocket expenditure of treated patients. 20 In the survey studies, there were mixed findings in relation to the association between general socioeconomic factors (such as employment, income and education) and screening status. Individuals without health insurance were less likely than those with insurance to have been tested, but household income was not associated with testing status. 44, 49 Not having a regular family physician was also found to be negatively associated with prior screening. 40, 46 Similarly, a positive correlation (OR: 10.5) was found between prior HBV vaccination and having a primary care physician. 39 A UK study reported that some immigrants do not register with primary health care. 59 In addition, other structural issues identified included limited consultation availability, long working hours, restrictions on the use of some healthcare services by immigrants, potentially affecting their engagement with HBV screening. 59 Chinese participants who reported not having less time or transportation were less likely to have been tested for HBV. 44 Language and communication difficulties were also identified as barriers to engagement with primary care-based screening and treatment for Chinese patients in the UK. 59 This mirrors similar findings from non-UK qualitative studies elsewhere. [55] [56] [57] Some of the survey studies found that those who needed an interpreter during doctor visits were less likely to have been tested, 40 while not speaking the physician's language was negatively associated with prior HBV vaccination. 39 Some immigrants have low levels of trust and confidence in UK general practice-based care that has been attributed to rushed appointments and delays in receiving treatment. 59 Key informants felt that a screening invitation letter might be ignored by some expecting to be contacted again if the screening was important and others fearing the knock-on implications in terms of further tests or treatment. 59 A lack of preventive healthcare seeking was highlighted, as well as the acceptance of poor health and a lack of familiarity with the healthcare system that contributed to low levels of health service engagement. 57 The use of complementary and alternative medicine (CAM) by
Chinese immigrants was another factor that was identified as undermining positive patient-provider interactions and potentially affecting appropriate HBV care. There was evidence that patients turn to CAM when told that hepatitis B is not curable with biomedicine. 53, 56 In addition, practitioners have mixed attitudes towards CAM and some practitioners suspect their nonacceptance of CAM could turn patients away. 55 Misunderstandings about HBV-related health care were further potential barriers to uptake. In the UK, healthcare providers identified adherence to treatment among some chronic hepatitis B immigrant patients to be poor and that this was because patients may not fully appreciate the value of monitoring or taking medication if they felt well. 59 Studies from the USA also found misunderstandings regarding testing: Korean groups did not understand the significance of screening prior to vaccination 56 and participants did not understand test results 52, 56 ; others were unclear about vaccination including fears of side effects 53, 54 and failed to recognize vaccination as a primary means of prevention. 53, 54, 56, 57 Reasons given by participants for not having been tested in some of the survey studies also suggested a lack of understanding regarding HBV infection and testing. The "lack of knowledge" and "feeling well" were commonly reported reasons for not being screened. 39 Among patients with CHB, many were concerned about the po- that this was dependent on the presence of risk factors in these patients. 43 The reasons given for not testing were primarily the cost of tests, physician considerations and patient resistance. In an Australian study, 70% of the Chinese respondents who had been vaccinated had received it in their country of origin. 47 Similarly, those who had lived a shorter proportion of their life in North America were significantly more likely to have had HBV testing which may reflect greater HBV prevention efforts in Asia than in North America.
42
A common theme in focus group discussions was adherence to the doctors' recommendations, both in relation to other medical matters and in relation to HBV testing 64 and vaccination. 54 Despite the fact that the majority of participants had healthcare providers who were conversant in Chinese, most reported no discussion of hepatitis B with their providers. 39 There was a positive association between reported prior HBV screening and reports that the doctor had suggested being tested (OR=2.4). Similarly, studies in Canada and USA found that those who reporting having had a test previously were more likely to have received a physician recommendation to do so (OR 9.04). [40] [41] [42] In a study of sources of information and its influence on testing uptake, 39% reported gaining information about HBV from physicians. The study concluded that "learning about HBV from physicians had the strongest direct effect" (p 779) on screening behaviour. 58 Further evidence shows that when participants were asked directly the reasons why they had not been tested, a common response was that the "doctor did not suggest it", 39 and the top reported reasons for being tested were when the tests were "mandatory" (43%) and "following physician advice" (16%). Survey respondents also suggested that they would consider testing whether they felt sick/ discomfort (35%) or whether instructed to by a doctor (21%). physicians 24 hours before a scheduled appointment with a patient with a Chinese surname. 37 The prompt included CDC recommendations for HBV testing in at-risk Asian populations, information about HBV prevalence and laboratory tests for HBV screening and also a link to facilitate the ordering of tests. The study found that among patients in the intervention arm, 41% received an order for, and 34% completed, an HBV test, compared to 1.1% and 0% in the control (care as usual) arm (P<.001).
| One dedicated service for immunization of newborn babies to hepatitis B-infected mothers shows improvement in vaccination coverage in the UK
One intervention implemented in London, UK, provided a dedicated centralized immunization service aimed at increasing immunization coverage among babies born between 1992 and 1996 to hepatitis B-positive mothers (a small proportion of whom were identified as "Oriental"). The setting is an inner city area, with high proportion of immigrants from high prevalence countries and high mobility. In the UK, only targeted immunization of babies is available through primary care. The study found that greater proactivity on the part of the health service, to contact mothers whose babies remain unimmunized and to provide flexible opportunities for completion of hepatitis B immunization course, was effective at improving coverage in comparison with a similar neighbouring area. 
| There is confounded evidence that education of healthcare practitioners is effective in increasing uptake of HBV screening, vaccination and treatment
Three survey papers examined practitioner knowledge. In one US study, most primary care physicians (83%) who knew that CHB was a serious condition were aware that the disease was prevalent in the Asian-American population. However, more than half (62%) were unfamiliar with the major treatment guidelines. 43 Of two US studies, in an area with a high Chinese population density, one showed that as much as 30% of providers could not identify the correct test for HBV screening despite the fact that all of the respondents knew that Chinese immigrants had a higher prevalence of chronic HBV than nonHispanic Whites or US-born Chinese people. 65 The study also found that providers who spoke an Asian language and had greater knowledge of HBV were more likely to report that they would screen their patients for HBV. 65 Another study that explored knowledge in hospital physicians by graded seniority, reported that only 24% could identify the appropriate serological tests, 41% could identify all the modes of transmission and 56% did not know they are mandated to report positive tests, correct responses were marginally higher in senior residents and physicians of Asian ethnicity (Chao et al 2015) . 67 Care may also be suboptimal for patients with the hepatitis B virus. A qualitative study found that little information about hepatitis B and its impact was given to participants at the point of diagnosis, and people with CHB had a poor understanding of their infection and had reservations regarding the capability of health professionals to respond effectively to their CHB queries. low-cost hepatitis B services. 25 The BeFreeNYC initiative in New York also included training for providers. 26 ,27 However, it was not possible ascertain the effect of these provider-focused interventions as they were part of complex multi-component interventions.
| DISCUSSION
The evidence base is currently skewed towards studies focused primarily on the knowledge and attitudes of Chinese immigrant groups including interventions to modify these, with less attention having been paid to practitioner attitudes and health system factors that could better support access to HBV screening, vaccination and care.
However, findings from this review suggest that interventions focused on the target population alone are unlikely to be efficacious. for it. 57, 59 There may also be some reticence within migrant Chinese populations to access care or testing, due to various barriers such as stigma 46, 48 or poor understanding of the disease and its risks. 38, 40 Primary care physicians are often the gatekeepers to HBV testing, vaccination and treatment and therefore hold an influential role in enabling access to services. 11 Economic barriers may exist, the thought that treatments might be unaffordable was found to be an influential factor in practitioners' decision to offer tests, 55 but it is not clear whether this is a shared decision: a process whereby the patient and the physician are involved in a discussion of informed options, and reach and agreement in the decision-making process. 66 If health workers make nonshared decisions that are in dissonance with the needs or choice of individuals, they may exert a disempowering effect in patients. A more comprehensive and holistic approach including health provider adaptations is required to improve the accessibility and acceptability of services. Enabling and empowering patients to successfully request tests and care for their individual needs also warrant attention.
A number of limitations of the reviewed evidence base, and our review methods, should be highlighted. Caution is warranted in extrapolating findings across often very divergent social and healthcare contexts. The majority of studies were published over the last 10 years and originate in USA, and there are very few studies from
T A B L E 4 Evidence statements
Poor knowledge of the disease as a barrier to HBV service uptake
There is strong, consistent evidence that knowledge about hepatitis B is low among immigrant Chinese populations and that common misconceptions are held regarding transmission routes, the seriousness of chronic infection and personal risk.
There is weak, consistent evidence that accurate knowledge can be improved via relatively brief, culturally tailored interventions and that such interventions are well received.
There is weak, equivocal evidence that levels of knowledge are associated with receipt of HBV testing and vaccination.
There is weak, consistent evidence that interventions focused on improving knowledge about HBV (without action on other barriers) can effect only modest increases in uptake of screening and vaccination.
Stigma as a barrier to HBV service uptake
There is strong, consistent evidence that HBV infection carries some stigma among immigrant Chinese populations.
There is weak, consistent evidence that stigma acts as a barrier to healthcare access among some people with CHB.
There is equivocal evidence that individually measured stigma is associated with past screening and vaccination for HBV.
There is confounded evidence on the effectiveness of interventions aimed at reducing HBV stigma on uptake of screening and vaccination.
Poor engagement with the healthcare system as a barrier to HBV service uptake
There is strong consistent evidence that immigrant Chinese individuals, particularly those who are new to their adoptive country, face a range of obstacles to engaging with routine healthcare services.
There is strong consistent evidence that immigrant Chinese individuals often have poor health service experiences, commonly undermined by communication problems, cultural distance and mistrust.
There is strong, consistent evidence that immigrant Chinese individuals often hold misunderstandings regarding the need for, and purpose of, testing for HBV infection.
There is confounded evidence that the provision of free or low-cost services that are culturally appropriate and geographically and temporally accessible are effective in increasing uptake of HBV screening, vaccination and treatment.
Missed opportunities within the healthcare system as a barrier to HBV service uptake
There is strong, consistent evidence that healthcare providers miss opportunities during routine healthcare encounters to refer Chinese immigrant individuals for screening and follow-up for HBV.
There is confounded evidence that education of healthcare practitioners is effective in increasing uptake of HBV screening, vaccination and treatment.
There is one strong study that concludes that simple prompts to primary healthcare physicians can increase referral for, and receipt of, HBV testing.
other countries, particularly those where public health services are provided free. However, low uptake is reported in healthcare settings where the services should be free as well as those where they might be dependent on particular insurance status.
An important limitation is that most of the studies reviewed were not informed by any explicit theory, and those that referenced theoretical models did not explicate them clearly. Indeed, a lack of detailed theory-driven process evaluations meant that it is not possible to ascertain and validate the efficacy of the various interventions employed or their mechanisms of action. There was also a dearth of robust evaluations of interventions. Most of the interventional studies were of low or medium quality, and there was a reliance on self-reported measures of healthcare uptake. A lack of controlled designs further compromised the strength of conclusions that could be drawn from many of these studies. There was also very little information on the costs of these interventions, and there were no detailed assessments of the cost-effectiveness of the interventions studied. Consequently, the findings from the various studies have been mixed. Further studies using more robust methodology to elucidate the effectiveness of interventions to boost HBV testing and care are required. In addition, practical strategies to improve the accessibility of healthcare services deserve further exploration.
Another limitation of the existing evidence base is that the diversity within and between Chinese subgroups was not explored in much detail in most studies. While some gender, age, socioeconomic and migration status differences were examined, the results were inconsistent and it was not easy to identify the relevance to diverse settings, other than the general need to recognize diversity and to exercise caution in generalizations. Records excluded due to low richness or quality (n=63)
| CONCLUSION
Migrant Chinese populations across the world are not a homogeneous group but extremely diverse in terms of their countries of origin, language and dialect groups, education levels, socioeconomic wealth and degree of acculturation, all of which are likely to have some bearing on their health seeking behaviours. Cognizance of this diversity is vital to ensure that interventions developed are tailored to the cultural and contextual specificities of each Chinese migrant community.
The current evidence base shows that low awareness, knowledge and access to testing and treatment for hepatitis B are a consistent pattern for migrant Chinese populations across diverse health service contexts. However, the evidence for interventions to address these healthcare gaps is patchy. Multi-pronged approaches to researching determinants of access, and to informing policy interventions, are necessary. It is likely that effective programmes to boost access to care and testing for hepatitis B will need to be carefully designed, multifaceted and target healthcare providers as well as the population groups, ensuring integration of programmes within the broader health systems.
